PPT-Figure 2 Figure 2. Determination of prevalence of tuberculosis (TB) and drug
Author : megan | Published Date : 2024-02-09
Shah N Richardson J Moodley P Moodley S Babaria P Ramtahal M et al Increasing Drug Resistance in Extensively DrugResistant Tuberculosis South Africa Emerg Infect
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Figure 2 Figure 2. Determinatio..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Figure 2 Figure 2. Determination of prevalence of tuberculosis (TB) and drug: Transcript
Shah N Richardson J Moodley P Moodley S Babaria P Ramtahal M et al Increasing Drug Resistance in Extensively DrugResistant Tuberculosis South Africa Emerg Infect Dis 2011173510513 httpsdoiorg103201eid1703101363. of Tuberculosis Internationally. Tuberculosis Control In Vulnerable Groups. Bulletin of the World Health Organization. TB is an in important public health problem in industrialized countries. Most cases occur in minority groups. TUBERCULOSIS. TUBERCULOSIS is an infectious disease caused by Mycobacteria; Mycobacterium tuberculosis & Mycobacterium . bovis. .. MODE OF TRANSMISSION. Inhalation. of droplets. Ingestion . --self swallowing of infected sputum/ or ingestion of . of Tuberculosis Internationally. Tuberculosis Control In Vulnerable Groups. Bulletin of the World Health Organization. TB is an in important public health problem in industrialized countries. Most cases occur in minority groups. Centers for Disease Control and Prevention. Division of Tuberculosis Elimination. 2016. . . CDC Self-Study Modules on Tuberculosis, 1-5 . Module 1: Transmission and Pathogenesis of TB. Module 2: Epidemiology of TB. Akujobi. CN, . Okoro. CE, . Anyabolu. AE, . Okonkwo. RC, . Onwunzo. MC and . Chukwuka. CP. Tuberculosis (TB) is the most common opportunistic infection in Human . Immuno. d. eficiency . Virus (HIV. Ireen Kiwelu. Kilimanjaro International PhD symposium. KCMC, Nov 28, 2013. Supervisors. Prof. . Max . Essex. 1. Dr. . Vladmir. . Novitsky. 1. Prof. . Saidi. . Kapiga. . 2. . Dr. Rachel Manongi. 91 and extensively drug resistant TB 92 and extensively drug resistant TBficient anti TB programs were the most affected by multi-resistance. Global resistance figures prov Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, et al. Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure. Emerg Infect Dis. 2009;15(7):1068-1076. https://doi.org/10.3201/eid1507.090043. Rattan A, Kalia A, Ahmad N. Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives. Emerg Infect Dis. 1998;4(2):195-209. https://doi.org/10.3201/eid0402.980207. Dierberg KL, Dorjee K, Salvo F, Cronin WA, Boddy J, Cirillo D, et al. Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India. Emerg Infect Dis. 2016;22(3):463-468. https://doi.org/10.3201/eid2203.140732. Brown T, Nikolayevskyy V, Velji P, Drobniewski F. Associations between Mycobacterium tuberculosis Strains and Phenotypes. Emerg Infect Dis. 2010;16(2):272-280. https://doi.org/10.3201/eid1602.091032. Ijaz K, Yang Z, Matthews HS, Bates JH, Cave MD. Mycobacterium tuberculosis Transmission between Cluster Members with Similar Fingerprint Patterns. Emerg Infect Dis. 2002;8(11):1257-1259. https://doi.org/10.3201/eid0811.020284. Story A, Bothamley G, Hayward A. Crack Cocaine and Infectious Tuberculosis. Emerg Infect Dis. 2008;14(9):1466-1469. https://doi.org/10.3201/eid1409.070654. Harbarth S, Albrich W, Brun-Buisson C. Outpatient Antibiotic Use and Prevalence of Antibiotic-Resistant Pneumococci in France and Germany: A Sociocultural Perspective. Emerg Infect Dis. 2002;8(12):1460-1467. https://doi.org/10.3201/eid0812.010533.
Download Document
Here is the link to download the presentation.
"Figure 2 Figure 2. Determination of prevalence of tuberculosis (TB) and drug"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents